EN
Call
400-6911558
Located in Hangzhou, China, HealthSky Biotechnology Co., Ltd. has been focusing on research and development, manufacturing, sales, and service in the field of Pathological Diagnosis since its establishment in 2004.
The product lines cover Liquid-Based Cytology and Histology Diagnosis.
Leveraging a profound understanding of pathological diagnosis, a professional R&D team, and state-of-the-art facilities, HealthSky is advancing the process of pathological diagnosis to be more standardized, automated, intelligent, and precise.
Continuous innovation drives HealthSky forward. HealthSky will keep striving for excellence, working for a healthier and brighter future for humans.
Square Meters Facilities Span
R&D Researchers
Invention Patents
Utility Patents
Embracing new technologies and approaches to healthcare delivery.
Adhering to ethical principles and professional standards.
Promote environmental and social responsibility.
Treating colleagues with dignity and professionalism.
We hold relevant patents and intellectual property that provide a competitive advantage.
Founded: HealthSky entered the field of Pathological Diagnosis.
Transformation: The company began R&D independently, transforming from a trading company to a comprehensive company integrating R&D, manufacturing and sales.
Expand: HealthSky Liquid-Based Cytology product series gained market share rapidly.
Upgrading: Health Sky became one of the leaders in the Liquid-Based Cytology market in China Hangzhou Bioin Biotechnology Co., Ltd. was founded and started the research of molecular pathological diagnosis.
2019, HealthSky committed to becoming the preeminent leader in pathology.
Integration: Hangzhou HealthSky Pathological Diagnosis Center was founded. One more step towards the Mission: Care for Health, Serve Pathology, Make Life Better.
New Era: Projects of Al, Telediagnosis Platform and Process Management System are underway.
New Market: HealthSky begins to expand into the global market.
HealthSky Big Family!
